Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Pharmaceutical Technology

MAY 25, 2023

The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. There was no significant difference in side effect profiles of the two vaccines, based on the data. percentage points (96% CI, −0.3 for serogroup W to 20.5

Side effects 78

Side effects Medicine Safety Marketing 78

European Pharmaceutical Review

MARCH 24, 2023

Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) side effects. In the European Union, NASH affects nearly 10 million people and is expected to increase by more than 40 percent by 2030. It is becoming the leading cause for liver transplants.

Medical 108

Medical Side effects Safety Pharmaceutical 108

PM360

AUGUST 9, 2022

billion in 2030 at a CAGR of 9.2%. This allows patients to complete the whole treatment process, from drug preparation and drug administration to treatment monitoring, side effect reporting, and communication, with one click on their device and smartphone. from 2021 and reach $4.2 billion in 2025.

Prescription 105

Prescription Medical Patients Side effects 105

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe side effects. from 2023 to 2030. Poised to grow at a CAGR of 29.4% The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

SEPTEMBER 30, 2022

. “What we cannot know yet is whether that effect increases over time in an individual. Another key factor to consider is the safety profile of the drug, particularly with regard to amyloid-related imaging abnormalities (ARIA) that are always a risk with amyloid-targeting drugs, causing oedema (ARIA-E) and haemorrhages (ARIA-H).

Doctors 52

Doctors Side effects Sales Safety 52